Author:
Brotchie Jonathan,Jenner Peter
Reference118 articles.
1. Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease;Antonini;CNS. Drugs,2010
2. Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease;Bara-Jimenez;Mov. Disord.,2004
3. Berg, D., Godau, J., Trenkwalder, C., Eggert, K., Csoti, I., Storch, A., Huber, H., Morelli-Canelo, M., Stamelou, M., Ries, V., Wolz, M., Schneider, C., Di, Paolo, T., Gasparini, F., Hariry, S., Vandemeulebroecke, M., Abi-Saab, W., Cooke, K., Johns, D., and Gomez-Mancilla, B. (2011). AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials. Mov. Disord.
4. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies;Bezard;Nat. Rev. Neurosci.,2001
5. Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function;Bezard;Nat. Med.,2003
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献